Concepedia
Statistics
Publications
58
Citations
4.1K
H-Index
26
Active since
1970
Affiliations
Eli Lilly (United States)(Current)
National University of Singapore
University of North Dakota
Eli Lilly (United Kingdom)
Guy's Hospital
Stephen L. Lowe is an author at Eli Lilly (United States) specializing in life sciences, neuropharmacology, and neuroscience.
Publications per year
1970–2024
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil, Lu Zhang, Ferenc Martényi et al. · Nature Medicine · 2007 · 1K citations
Medicine, Pharmacology, Psychiatry +12
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
Patrick C. May, Robert A. Dean, Stephen L. Lowe et al. · Journal of Neuroscience · 2011 · 369 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans
Patrick C. May, Brian A. Willis, Stephen L. Lowe et al. · Journal of Neuroscience · 2015 · 205 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +17
Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease
Andrew Procter, Alan M. Palmer, Paul T. Francis et al. · Journal of Neurochemistry · 1988 · 197 citations
Life Sciences, Neurology, Neuroscience +17
Topographical distribution of neurochemical changes in Alzheimer's disease
Andrew Procter, Stephen L. Lowe, Alan M. Palmer et al. · Journal of the Neurological Sciences · 1988 · 136 citations
Life Sciences, Neurobiology, Neuroscience +14
1–5 of 58